Status:
UNKNOWN
Investigation of the Genetic Diseases in Infants With Unknown Cause of Death
Lead Sponsor:
Ankara University
Conditions:
Sudden Infant Death
Eligibility:
All Genders
1-12 years
Brief Summary
Sudden infant death syndrome (SIDS) is a disease of an infant under one year of age, whose sudden death occurred unexpectedly, which the cause of death cannot be determined despite macro-autopsy, and ...
Eligibility Criteria
Inclusion
- Under one year of age, who died unexpectedly and suddenly, whose cause of death could not be determined despite the death examination, autopsy, toxicological, pathological and microbiological examinations carried out on the internal organ samples and body fluids taken during the autopsy by the Forensic Medicine Institute Ankara Group Presidency between 2018 and 2023.
- Witness blood samples taken during the autopsies of the patients will be evaluated, and peripheral blood samples of 100 patients, stored under appropriate conditions, will be transferred to the genetic laboratory for DNA isolation and genetic study.
Exclusion
- Patients with findings indicating congenital structural anomalies or known genetic syndromes during autopsy will not be included in the study.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06060249
Start Date
September 1 2023
End Date
January 1 2025
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hatice Mutlu
Ankara, Not US Or Canada, Turkey (Türkiye), 06790